ANASTROZOLE

Anastrozole Adverse Events Reported to the FDA Over Time

How are Anastrozole adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Anastrozole, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Anastrozole is flagged as the suspect drug causing the adverse event.

Most Common Anastrozole Adverse Events Reported to the FDA

What are the most common Anastrozole adverse events reported to the FDA?

Arthralgia	72 (3.3%)
Pain	40 (1.83%)
Headache	33 (1.51%)
Dyspnoea	31 (1.42%)
Fatigue	30 (1.37%)
Pain In Extremity	27 (1.24%)
Depression	26 (1.19%)
Hot Flush	25 (1.14%)
Nausea	24 (1.1%)
Diarrhoea	23 (1.05%)
Product Substitution Issue	23 (1.05%)
	Show More
Vomiting	22 (1.01%)
Dizziness	21 (.96%)
Anxiety	19 (.87%)
Alopecia	18 (.82%)
Hyponatraemia	18 (.82%)
Suicidal Ideation	18 (.82%)
Breast Cancer	17 (.78%)
Pulmonary Embolism	17 (.78%)
Adverse Drug Reaction	16 (.73%)
Asthenia	16 (.73%)
Cough	16 (.73%)
Myalgia	16 (.73%)
Insomnia	14 (.64%)
Joint Swelling	14 (.64%)
Bone Pain	13 (.59%)
Condition Aggravated	13 (.59%)
Cutaneous Vasculitis	13 (.59%)
Drug Interaction	13 (.59%)
Hip Fracture	13 (.59%)
Cardiac Failure Congestive	12 (.55%)
Feeling Abnormal	12 (.55%)
Myocardial Ischaemia	12 (.55%)
Osteopenia	12 (.55%)
Pleural Effusion	12 (.55%)
Pruritus	12 (.55%)
Sudden Death	12 (.55%)
Hepatic Function Abnormal	11 (.5%)
Paraesthesia	11 (.5%)
Weight Increased	11 (.5%)
Joint Stiffness	10 (.46%)
Metastases To Bone	10 (.46%)
Myocardial Infarction	10 (.46%)
Oedema Peripheral	10 (.46%)
Osteonecrosis	10 (.46%)
Weight Decreased	10 (.46%)
Anaemia	9 (.41%)
Back Pain	9 (.41%)
Chest Pain	9 (.41%)
Drug Ineffective	9 (.41%)
Drug Intolerance	9 (.41%)
Hypoaesthesia	9 (.41%)
Memory Impairment	9 (.41%)
Metastases To Liver	9 (.41%)
Palpitations	9 (.41%)
Abdominal Pain Upper	8 (.37%)
Blood Pressure Increased	8 (.37%)
Drug Dose Omission	8 (.37%)
Drug Hypersensitivity	8 (.37%)
Gait Disturbance	8 (.37%)
Gastrooesophageal Reflux Disease	8 (.37%)
Malaise	8 (.37%)
Phlebitis	8 (.37%)
Blood Pressure Decreased	7 (.32%)
Bundle Branch Block Left	7 (.32%)
Chills	7 (.32%)
Decreased Appetite	7 (.32%)
Dehydration	7 (.32%)
Disturbance In Attention	7 (.32%)
Hallucination, Visual	7 (.32%)
Hyperhidrosis	7 (.32%)
Mood Swings	7 (.32%)
Musculoskeletal Stiffness	7 (.32%)
Pyrexia	7 (.32%)
Skin Lesion	7 (.32%)
Syncope	7 (.32%)
Transient Acantholytic Dermatosis	7 (.32%)
Adverse Event	6 (.27%)
Blood Cholesterol Increased	6 (.27%)
Blood Glucose Increased	6 (.27%)
Breast Cancer Metastatic	6 (.27%)
Burning Sensation	6 (.27%)
Cholestasis	6 (.27%)
Constipation	6 (.27%)
Drug Eruption	6 (.27%)
Hepatic Encephalopathy	6 (.27%)
Hyperkalaemia	6 (.27%)
Hypokalaemia	6 (.27%)
Loss Of Libido	6 (.27%)
Malignant Neoplasm Progression	6 (.27%)
Mobility Decreased	6 (.27%)
Musculoskeletal Pain	6 (.27%)
Pancytopenia	6 (.27%)
Platelet Count Decreased	6 (.27%)
Sleep Disorder	6 (.27%)
Tremor	6 (.27%)
Abdominal Pain	5 (.23%)
Alanine Aminotransferase Increased	5 (.23%)
Anger	5 (.23%)
Antinuclear Antibody Positive	5 (.23%)
Aplastic Anaemia	5 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Anastrozole, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Anastrozole is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Anastrozole

What are the most common Anastrozole adverse events reported to the FDA?

Joint	115 (5.26%)
Epidermal And Dermal Conditions	81 (3.71%)
Gastrointestinal Signs	80 (3.66%)
Neurological	80 (3.66%)
Musculoskeletal And Connective Tiss...	69 (3.16%)
Respiratory	61 (2.79%)
Therapeutic And Nontherapeutic Effe...	59 (2.7%)
Hepatic And Hepatobiliary	58 (2.65%)
Bone Disorders	51 (2.33%)
Electrolyte And Fluid Balance Condi...	40 (1.83%)
Depressed Mood Disorders	38 (1.74%)
	Show More
Cardiac Arrhythmias	37 (1.69%)
Gastrointestinal Motility And Defec...	37 (1.69%)
Headaches	36 (1.65%)
Infections - Pathogen Unspecified	35 (1.6%)
Skin Appendage Conditions	32 (1.46%)
Breast Neoplasms Malignant And Unsp...	31 (1.42%)
Muscle	31 (1.42%)
Metastases	29 (1.33%)
Vascular	29 (1.33%)
Bone And Joint Injuries	28 (1.28%)
Anemias Nonhemolytic And Marrow Dep...	26 (1.19%)
Hematology Investigations	25 (1.14%)
Mental Impairment	25 (1.14%)
Anxiety Disorders	24 (1.1%)
Product Quality Issues	24 (1.1%)
Coronary Artery	23 (1.05%)
Physical Examination Topics	22 (1.01%)
Sleep Disorders	22 (1.01%)
Enzyme	21 (.96%)
Skin Vascular Abnormalities	21 (.96%)
Cardiac And Vascular Investigations	20 (.92%)
Hepatobiliary	19 (.87%)
Mood Disorders	18 (.82%)
Pulmonary Vascular	18 (.82%)
Suicidal And Self-injurious Behavio...	18 (.82%)
Allergic Conditions	17 (.78%)
Injuries	17 (.78%)
Heart Failures	16 (.73%)
Fatal Outcomes	15 (.69%)
Vision	15 (.69%)
Cardiac Disorder Signs	14 (.64%)
Bacterial Infectious	13 (.59%)
Pleural	13 (.59%)
Central Nervous System Vascular	11 (.5%)
Lifestyle Issues	11 (.5%)
Miscellaneous And Site Unspecified ...	11 (.5%)
Myocardial	11 (.5%)
Breast	10 (.46%)
Leukemias	10 (.46%)
Lower Respiratory Tract Disorders	10 (.46%)
Medication Errors	10 (.46%)
Oral Soft Tissue Conditions	10 (.46%)
Appetite And General Nutritional	9 (.41%)
Embolism And Thrombosis	9 (.41%)
Metabolic, Nutritional And Blood Ga...	9 (.41%)
Vascular Inflammations	9 (.41%)
Dental And Gingival Conditions	8 (.37%)
Disturbances In Thinking	8 (.37%)
Lipid Analyses	8 (.37%)
Movement Disorders	8 (.37%)
Platelet	8 (.37%)
Upper Respiratory Tract Disorders	8 (.37%)
Body Temperature Conditions	7 (.32%)
Connective Tissue Disorders	7 (.32%)
Eye	7 (.32%)
Skin And Subcutaneous Tissue	7 (.32%)
Thyroid Gland	7 (.32%)
White Blood Cell	7 (.32%)
Deliria	6 (.27%)
Encephalopathies	6 (.27%)
Inner Ear And Viiith Cranial Nerve	6 (.27%)
Investigations, Imaging And Histopa...	6 (.27%)
Neoplasm Related Morbidities	6 (.27%)
Peritoneal And Retroperitoneal Cond...	6 (.27%)
Reproductive Tract	6 (.27%)
Sexual Dysfunctions, Disturbances A...	6 (.27%)
Therapeutic Procedures And Supporti...	6 (.27%)
Vascular Hypertensive	6 (.27%)
Angiedema And Urticaria	5 (.23%)
Decreased And Nonspecific Blood Pre...	5 (.23%)
Gastrointestinal Conditions	5 (.23%)
Glucose Metabolism Disorders	5 (.23%)
Immunology And Allergy	5 (.23%)
Peripheral Neuropathies	5 (.23%)
Personality Disorders	5 (.23%)
Salivary Gland Conditions	5 (.23%)
Tongue Conditions	5 (.23%)
Urinary Tract Signs	5 (.23%)
Viral Infectious	5 (.23%)
Vulvovaginal Disorders	5 (.23%)
Gastrointestinal Ulceration And Per...	4 (.18%)
Hematological	4 (.18%)
Microbiology And Serology	4 (.18%)
Psychiatric And Behavioural Symptom...	4 (.18%)
Renal And Urinary Tract Investigati...	4 (.18%)
Renal Disorders	4 (.18%)
Tissue	4 (.18%)
Aneurysms And Artery Dissections	3 (.14%)
Arteriosclerosis, Stenosis, Vascula...	3 (.14%)
Cranial Nerve Disorders	3 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Anastrozole, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Anastrozole is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.